• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Basilea Pharmaceutica

+ Add to Watchlist

BSLN:SW

95.00 CHF 0.000.00%

As of 11:43:40 ET on 04/23/2014.

Snapshot for Basilea Pharmaceutica (BSLN)

Open: 95.85 Day's Range: 94.10 - 97.50 Volume: 107,044
Previous Close: 95.00 52wk Range: 50.40 - 129.80 1-Yr Rtn: +82.69%

Stock Chart for BSLN

No chart data available.
  • BSLN:SW 95.00
  • 1D
  • 1M
  • 1Y
95.00
Interactive BSLN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BSLN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -3.4000
Est. EPS (CHF) (12/2014) -3.6300
Est. PEG Ratio -
Market Cap (M CHF) 989.97
Shares Outstanding (M) 10.42
30 Day Average Volume 138,452
Price/Book (mrq) 13.6725
Price/Sale (ttm) 22.3892
Dividend Indicated Gross Yield -%
Cash Dividend (CHF) 5.0000
Dividend Ex-Date 04/11/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BSLN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for BSLN

Basilea Pharmaceutica AG is a biotechnology company conducting research into the development of drugs for the treatment of infectious diseases and dermatological problems. The Company develops anti-bacterial and anti-fungal compounds which destroy infectious organisms.

Martin NicklassonChairmanDomenico ScalaVice Chairman
Ronald Scott "Ron"Chief Executive OfficerDonato SpotaChief Financial Officer
More Company Profile & Key Executives for BSLN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil